Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Talk Evidence covid-19 update - Confused symptoms, fatality rate uncertainty, Iceland’s testing

Talk Evidence covid-19 update - Confused symptoms, fatality rate uncertainty, Iceland’s testing

FromThe BMJ Podcast


Talk Evidence covid-19 update - Confused symptoms, fatality rate uncertainty, Iceland’s testing

FromThe BMJ Podcast

ratings:
Length:
40 minutes
Released:
Mar 27, 2020
Format:
Podcast episode

Description

For the next few months Talk Evidence is going to focus on the new corona virus pandemic.

There is an enormous amount of uncertainty about the disease, what the symptoms are, fatality rate, treatment options, things we shouldn't be doing.

We're going to try to get away from the headlines and talk about what we need to know - to hopefully give you some insight into these issues.

This week

3.50 - There is a lot of confusion around symptoms, we hear what Carl's review of the case studies has found, and why he thinks fever and persistent dry cough may not be a sign of all cases.

10.30 - where are we with research into antiviral treatment

17.30 - John Ioannidis has expressed concerns about the quality data used in modelling and therefore our pandemic response. We hear what his concerns are, and what needs to be done to answer them.

29.10 - Iceland is the only country attempting to do population level screening, we hear from Kári Stefánsson, CEO of deCODE genetics which is working with the Icelandic government to allow everyone to access testing for the virus.
Released:
Mar 27, 2020
Format:
Podcast episode

Titles in the series (100)

The BMJ is an international peer reviewed medical journal and a fully “online first” publication. The BMJ’s vision is to be the world’s most influential and widely read medical journal. Our mission is to lead the debate on health and to engage, inform, and stimulate doctors, researchers, and other health professionals in ways that will improve outcomes for patients. We aim to help doctors to make better decisions.